Search alternatives:
significant substantial » significant potential (Expand Search), significant spatial (Expand Search)
substantial decrease » substantial increase (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant substantial » significant potential (Expand Search), significant spatial (Expand Search)
substantial decrease » substantial increase (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
-
2241
-
2242
Verification of PLUS CYCLE<sup>®</sup> signals during presumed sleep periods.
Published 2025Subjects: -
2243
-
2244
-
2245
Combination therapy exhibited apoptosis in Ba/F3 EML4-ALKmutant cell models.
Published 2025Subjects: -
2246
-
2247
The characteristics of patient groups were used to prove the method’s applicability.
Published 2025Subjects: -
2248
-
2249
-
2250
-
2251
ROS, K<sup>+</sup> efflux and cathepsin B are required for NLRP3 activation.
Published 2025Subjects: -
2252
-
2253
-
2254
-
2255
Differences in health-related quality of life indexes after disease onset between groups.
Published 2025Subjects: -
2256
Changes in subcutaneous fat thickness and muscle mass (Approximately here).
Published 2025Subjects: -
2257
-
2258
-
2259
Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment.
Published 2025Subjects: -
2260